[
    [
        {
            "time": "2021-08-15",
            "original_text": "Pfizer, Biotech vaccine shows strong results after 6 months",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Biotech",
                    "vaccine",
                    "strong results"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pfizer, Biotech vaccine shows strong results after 6 months",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-16",
            "original_text": "Abbott-Quidel Rapid COVID-19 Test Cleared by FDA",
            "features": {
                "keywords": [
                    "Abbott-Quidel",
                    "Rapid",
                    "COVID-19",
                    "Test",
                    "Cleared",
                    "FDA"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott-Quidel Rapid COVID-19 Test Cleared by FDA",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-17",
            "original_text": "Abbott’s BinaxNOW COVID-19 Ag Self Test Cleared For Emergency Use In US",
            "features": {
                "keywords": [
                    "Abbott",
                    "BinaxNOW",
                    "COVID-19",
                    "Self Test",
                    "Emergency Use",
                    "US"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "diagnostics"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott’s BinaxNOW COVID-19 Ag Self Test Cleared For Emergency Use In US",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "U.S. okays Abbott's rapid COVID-19 test for at-home screenings in those without symptoms",
            "features": {
                "keywords": [
                    "U.S.",
                    "Abbott",
                    "rapid",
                    "COVID-19",
                    "test",
                    "at-home",
                    "screenings",
                    "without symptoms"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "diagnostics"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "U.S. okays Abbott's rapid COVID-19 test for at-home screenings in those without symptoms",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-19",
            "original_text": "Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use",
            "features": {
                "keywords": [
                    "Abbott",
                    "BinaxNOW™",
                    "Rapid Antigen",
                    "Self Test",
                    "FDA",
                    "Emergency Use Authorization",
                    "Asymptomatic",
                    "Over-the-Counter",
                    "Non-Prescription",
                    "Multi-Test Use"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "diagnostics"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]